Pacific View Asset Management, Llc Buys Granite Construction Inc, Global X Uranium, Array BioPharma Inc, Sells Monro Inc, Schneider National Inc, Maxwell Technologies Inc

Investment company Pacific View Asset Management, Llc buys Granite Construction Inc, Global X Uranium, Array BioPharma Inc, Aerie Pharmaceuticals Inc, Pinnacle Financial Partners Inc, Aimmune Therapeutics Inc, Sage Therapeutics Inc, Investors Bancorp Inc, PRA Health Sciences Inc, ABM Industries Inc, sells Monro Inc, Schneider National Inc, Maxwell Technologies Inc, LHC Group Inc, Nektar Therapeutics Inc during the 3-months ended 2018-06-30, according to the most recent filings of the investment company, Pacific View Asset Management, Llc. As of 2018-06-30, Pacific View Asset Management, Llc owns 95 stocks with a total value of $126 million. These are the details of the buys and sells.

For the details of PACIFIC VIEW ASSET MANAGEMENT, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=PACIFIC+VIEW+ASSET+MANAGEMENT%2C+LLC

These are the top 5 holdings of PACIFIC VIEW ASSET MANAGEMENT, LLC
  1. Gulf Island Fabrication Inc (GIFI) - 800,846 shares, 5.71% of the total portfolio. Shares added by 2.36%
  2. Universal Technical Institute Inc (UTI) - 2,190,962 shares, 5.46% of the total portfolio. Shares added by 14.82%
  3. Kindred Biosciences Inc (KIN) - 545,000 shares, 4.59% of the total portfolio. Shares added by 11.22%
  4. Sage Therapeutics Inc (SAGE) - 35,174 shares, 4.36% of the total portfolio. Shares added by 63.78%
  5. GSE Systems Inc (GVP) - 1,661,332 shares, 4.27% of the total portfolio. Shares added by 0.15%
New Purchase: Global X Uranium (URA)

Pacific View Asset Management, Llc initiated holding in Global X Uranium. The purchase prices were between $12.1 and $14.71, with an estimated average price of $13.49. The stock is now traded at around $12.70. The impact to a portfolio due to this purchase was 3.1%. The holding were 304,000 shares as of 2018-06-30.

New Purchase: Array BioPharma Inc (ARRY)

Pacific View Asset Management, Llc initiated holding in Array BioPharma Inc. The purchase prices were between $13.49 and $19.99, with an estimated average price of $15.91. The stock is now traded at around $14.27. The impact to a portfolio due to this purchase was 3%. The holding were 225,511 shares as of 2018-06-30.

New Purchase: ABM Industries Inc (ABM)

Pacific View Asset Management, Llc initiated holding in ABM Industries Inc. The purchase prices were between $28.49 and $33.54, with an estimated average price of $30.85. The stock is now traded at around $31.19. The impact to a portfolio due to this purchase was 1.02%. The holding were 44,209 shares as of 2018-06-30.

New Purchase: Limbach Holdings Inc (LMB)

Pacific View Asset Management, Llc initiated holding in Limbach Holdings Inc. The purchase prices were between $10.79 and $13.81, with an estimated average price of $12.17. The stock is now traded at around $10.70. The impact to a portfolio due to this purchase was 0.85%. The holding were 90,860 shares as of 2018-06-30.

New Purchase: Global X Silver Miners (SIL)

Pacific View Asset Management, Llc initiated holding in Global X Silver Miners. The purchase prices were between $28.35 and $31.81, with an estimated average price of $30.4. The stock is now traded at around $25.59. The impact to a portfolio due to this purchase was 0.74%. The holding were 32,500 shares as of 2018-06-30.

New Purchase: Callon Petroleum Co (CPE)

Pacific View Asset Management, Llc initiated holding in Callon Petroleum Co. The purchase prices were between $9.88 and $14.26, with an estimated average price of $12.41. The stock is now traded at around $11.17. The impact to a portfolio due to this purchase was 0.61%. The holding were 71,497 shares as of 2018-06-30.

Added: Granite Construction Inc (GVA)

Pacific View Asset Management, Llc added to a holding in Granite Construction Inc by 860.13%. The purchase prices were between $52.38 and $59.42, with an estimated average price of $56.51. The stock is now traded at around $42.97. The impact to a portfolio due to this purchase was 3.52%. The holding were 89,110 shares as of 2018-06-30.

Added: Aerie Pharmaceuticals Inc (AERI)

Pacific View Asset Management, Llc added to a holding in Aerie Pharmaceuticals Inc by 179.16%. The purchase prices were between $47.85 and $70.45, with an estimated average price of $56.02. The stock is now traded at around $65.75. The impact to a portfolio due to this purchase was 2.36%. The holding were 68,666 shares as of 2018-06-30.

Added: Pinnacle Financial Partners Inc (PNFP)

Pacific View Asset Management, Llc added to a holding in Pinnacle Financial Partners Inc by 87.87%. The purchase prices were between $61.35 and $68.1, with an estimated average price of $64.93. The stock is now traded at around $64.20. The impact to a portfolio due to this purchase was 1.84%. The holding were 81,021 shares as of 2018-06-30.

Added: Aimmune Therapeutics Inc (AIMT)

Pacific View Asset Management, Llc added to a holding in Aimmune Therapeutics Inc by 78.58%. The purchase prices were between $26.56 and $33.2, with an estimated average price of $30.57. The stock is now traded at around $28.28. The impact to a portfolio due to this purchase was 1.82%. The holding were 194,628 shares as of 2018-06-30.

Added: Sage Therapeutics Inc (SAGE)

Pacific View Asset Management, Llc added to a holding in Sage Therapeutics Inc by 63.78%. The purchase prices were between $140.36 and $175.76, with an estimated average price of $157.06. The stock is now traded at around $150.17. The impact to a portfolio due to this purchase was 1.7%. The holding were 35,174 shares as of 2018-06-30.

Added: Investors Bancorp Inc (ISBC)

Pacific View Asset Management, Llc added to a holding in Investors Bancorp Inc by 87.61%. The purchase prices were between $12.79 and $13.81, with an estimated average price of $13.48. The stock is now traded at around $12.78. The impact to a portfolio due to this purchase was 1.61%. The holding were 341,153 shares as of 2018-06-30.

Sold Out: Monro Inc (MNRO)

Pacific View Asset Management, Llc sold out a holding in Monro Inc. The sale prices were between $52.15 and $61.5, with an estimated average price of $56.47.

Sold Out: Schneider National Inc (SNDR)

Pacific View Asset Management, Llc sold out a holding in Schneider National Inc. The sale prices were between $24.9 and $30.24, with an estimated average price of $27.74.

Sold Out: Nektar Therapeutics Inc (NKTR)

Pacific View Asset Management, Llc sold out a holding in Nektar Therapeutics Inc. The sale prices were between $46.25 and $104.45, with an estimated average price of $76.82.

Sold Out: Sonic Corp (SONC)

Pacific View Asset Management, Llc sold out a holding in Sonic Corp. The sale prices were between $24.31 and $35.63, with an estimated average price of $27.89.

Sold Out: Forward Air Corp (FWRD)

Pacific View Asset Management, Llc sold out a holding in Forward Air Corp. The sale prices were between $52.14 and $63.38, with an estimated average price of $57.21.

Sold Out: Globus Medical Inc (GMED)

Pacific View Asset Management, Llc sold out a holding in Globus Medical Inc. The sale prices were between $47.96 and $57.41, with an estimated average price of $52.09.

Reduced: Maxwell Technologies Inc (MXWL)

Pacific View Asset Management, Llc reduced to a holding in Maxwell Technologies Inc by 89.23%. The sale prices were between $5.13 and $5.82, with an estimated average price of $5.43. The stock is now traded at around $3.99. The impact to a portfolio due to this sale was -1.03%. Pacific View Asset Management, Llc still held 26,932 shares as of 2018-06-30.

Reduced: LHC Group Inc (LHCG)

Pacific View Asset Management, Llc reduced to a holding in LHC Group Inc by 75.01%. The sale prices were between $62.98 and $86.87, with an estimated average price of $76.21. The stock is now traded at around $94.71. The impact to a portfolio due to this sale was -0.92%. Pacific View Asset Management, Llc still held 6,409 shares as of 2018-06-30.

Reduced: TransEnterix Inc (TRXC)

Pacific View Asset Management, Llc reduced to a holding in TransEnterix Inc by 74.77%. The sale prices were between $1.68 and $5.84, with an estimated average price of $2.79. The stock is now traded at around $4.33. The impact to a portfolio due to this sale was -0.52%. Pacific View Asset Management, Llc still held 131,106 shares as of 2018-06-30.

Reduced: Pricesmart Inc (PSMT)

Pacific View Asset Management, Llc reduced to a holding in Pricesmart Inc by 45.04%. The sale prices were between $81.75 and $93.83, with an estimated average price of $86.99. The stock is now traded at around $83.70. The impact to a portfolio due to this sale was -0.4%. Pacific View Asset Management, Llc still held 7,403 shares as of 2018-06-30.

Reduced: EastGroup Properties Inc (EGP)

Pacific View Asset Management, Llc reduced to a holding in EastGroup Properties Inc by 65.28%. The sale prices were between $80.99 and $95.95, with an estimated average price of $89.94. The stock is now traded at around $96.28. The impact to a portfolio due to this sale was -0.33%. Pacific View Asset Management, Llc still held 2,714 shares as of 2018-06-30.

Reduced: Encompass Health Corp (EHC)

Pacific View Asset Management, Llc reduced to a holding in Encompass Health Corp by 48.43%. The sale prices were between $55.68 and $69.24, with an estimated average price of $62.79. The stock is now traded at around $79.76. The impact to a portfolio due to this sale was -0.31%. Pacific View Asset Management, Llc still held 7,585 shares as of 2018-06-30.



Here is the complete portfolio of PACIFIC VIEW ASSET MANAGEMENT, LLC. Also check out:

1. PACIFIC VIEW ASSET MANAGEMENT, LLC's Undervalued Stocks
2. PACIFIC VIEW ASSET MANAGEMENT, LLC's Top Growth Companies, and
3. PACIFIC VIEW ASSET MANAGEMENT, LLC's High Yield stocks
4. Stocks that PACIFIC VIEW ASSET MANAGEMENT, LLC keeps buying